Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

ACCC and its partner programs are working together on numerous projects aimed at improving the quality of patient care and survival rates for all women diagnosed with gynecologic cancer.
Multiple myeloma, also known as myeloma, is the third most common hematologic cancer (cancer of the blood).
Immunotherapies are rapidly advancing and yielding impressive clinical benefits in a growing number of cancers, and as new drugs are introduced and clinical indications are expanded for existing drugs in this class, immunotherapy usage in cancer care is expected to increase. However, with this growth comes new challenges for community cancer care programs, as oncologists and multidisciplinary care …
Developing quality improvement programs aimed at reducing health care disparities and improving the standard of care received by patients with hematologic cancers are key priorities in ACCC’s educational portfolio.
Developing quality improvement programs aimed at reducing health care disparities and improving the standard of care received by patients with hematologic cancers are key priorities in ACCC’s educational portfolio.
Care Coordination includes projects and resources on eliminating disparities in precision medicine, genetic counseling, and precision medicine stewardship.
The five-year survival rate for uterine cancer is 81%, cervical cancer is 67.2%, for ovarian it is 50.8%. However, these statistics vary based on treatment outcomes.
Myelodysplastic syndromes (MDS) constitute a rare category of bone marrow disorders. These syndromes are characterized by inadequate production of healthy blood cells in the bone marrow, leading to the accumulation of abnormal cells that overcrowd the marrow, called blasts.
NCCN Guidelines define an adolescent and young adult (AYA) oncology patient as an individual between 15 and 39 years of age at the time of initial diagnosis.
Publications Comprehensive Care of Patients with Advanced Prostate Cancer through Shared Decision-Making: Landscape Analysis. By reviewing the current state of personal engagement in decision-making for patients with advanced prostate cancer, this paper identifies obstacles to shared decision-making proposes new ways to better educate patients about their treatment options. Overcoming Prostate Cancer …
Ovarian cancer ranks fifth in cancer deaths among U.S. women. At the early stages of this disease many women are asymptomatic or experience symptoms attributable to other health issues.
BiomarkerLIVE ACCC launched BiomarkerLIVE in 2019 with the goal of improving communication about biomarkers and molecular profiling among cancer care teams. Now in its second phase, this project is currently focused on helping cancer providers facilitate the integration of precision medicine into their daily practice. Learn More Biomarker Testing In partnership with Pfizer Global Medical …
Liver cancer, which includes hepatocellular carcinoma (HCC), is the second leading cause of cancer-related death globally, responsible for more than 700,000 deaths worldwide each year.
Cancer care treatment includes programs on managing adverse events, usage of biosimilars in treatment, bispecific antibodies, and immunotherapy.
To improve quality of care and quality of life for patients with myelofibrosis, the Association of Community Cancer Centers (ACCC) has developed an initiative titled, Advancements in Treating Patients with Myelofibrosis and Strategies to Improve Care.
ACCC has developed this initiative which will foster knowledge sharing, raise awareness about available care guidelines and resources to better manage symptoms, and improve the quality of care for patients with myeloproliferative neoplasms.
Developing quality improvement programs aimed at reducing health care disparities and improving the standard of care received by patients with hematologic cancers are key priorities in ACCC’s educational portfolio.
Developing quality improvement programs aimed at reducing health care disparities and improving the standard of care received by patients with hematologic cancers are key priorities in ACCC’s educational portfolio.
African Americans are disproportionately affected by the prevalence and severity of breast cancer and consistently exhibit poorer health outcomes. For example, African American women have a higher risk of developing triple negative breast cancer (TNBC)—which represents approximately 15% to 20% of all breast cancer cases—than any other racial or ethnic group. A 2021 publication from the Tigerlily Foundation …
Myelodysplastic syndromes (MDS) constitute a rare category of bone marrow disorders. These syndromes are characterized by inadequate production of healthy blood cells in the bone marrow, leading to the accumulation of abnormal cells that overcrowd the marrow, called blasts.